Bildkälla: Stockfoto

SyntheticMR: 3D launch in focus in 2024 - SEB

At SEB's Nordic Seminar, CEO Ulrik Harrysson outlined the company's strategy towards becoming a standard of care, and highlighted key advancements such as the strengthened OEM partnerships, vastly improved pricing points and transition to time-based licenses. With the planned launch of SyMRI 3D in Q1, combined with no larger investment needs, we believe 2024 could be an exciting year for SyntheticMR.

At SEB's Nordic Seminar, CEO Ulrik Harrysson outlined the company's strategy towards becoming a standard of care, and highlighted key advancements such as the strengthened OEM partnerships, vastly improved pricing points and transition to time-based licenses. With the planned launch of SyMRI 3D in Q1, combined with no larger investment needs, we believe 2024 could be an exciting year for SyntheticMR.
Börsvärldens nyhetsbrev
ANNONSER